Hemorrhagic fever viruses as biological weapons: medical and public health management.

@article{Borio2002HemorrhagicFV,
  title={Hemorrhagic fever viruses as biological weapons: medical and public health management.},
  author={Luciana L. Borio and Thomas V. Inglesby and Clarence J. Peters and Alan L. Schmaljohn and James M. Hughes and Peter B. Jahrling and Thomas Ksiazek and Karl M. Johnson and Andrea Meyerhoff and Tara O'Toole and Michael S. Ascher and John G. Bartlett and Joel G. Breman and Edward M. Eitzen and Margaret A. Hamburg and Jerome Hauer and Donald Ainslie Henderson and Richard T. Johnson and Gigi Kwik and Marci Layton and Scott R. Lillibridge and Gary J. Nabel and Michael T. Osterholm and Trish M. Perl and Philip K. Russell and Kevin Tonat},
  journal={JAMA},
  year={2002},
  volume={287 18},
  pages={
          2391-405
        }
}
OBJECTIVE To develop consensus-based recommendations for measures to be taken by medical and public health professionals if hemorrhagic fever viruses (HFVs) are used as biological weapons against a civilian population. [] Key MethodEVIDENCE MEDLINE was searched from January 1966 to January 2002. Retrieved references, relevant material published prior to 1966, and additional sources identified by participants were reviewed.

Figures and Tables from this paper

Recognition and management of bioterrorism infections.

Defense against filoviruses used as biological weapons.

  • M. Bray
  • Medicine
    Antiviral research
  • 2003

Hemorrhagic Fever Viruses

The biological weapons potential of and defense against the major hemorrhagic fever viruses are discussed.

Viral hemorrhagic fever.

Some hemorrhagic fever (HF) viruses are considered to pose a serious threat as potential biological weapons based on their risk of morbidity and mortality, feasibility of production, and their ability to cause infection through aerosol dissemination.

Medical Countermeasures for Filoviruses and Other Viral Agents

Many viruses were considered historically and have been reconsidered recently as potential agents of great harm, through intentional release as weapons of biological warfare or bioterrorism. Two such

History of U.S. military contributions to the study of viral hemorrhagic fevers.

The characteristics of the viral hemorrhagic fever viruses as arthropod-borne or rodent-borne viruses that can result in human illnesses with high morbidity and mortality rates make these viruses a unique threat, historically, currently, and in the future, to deployed soldiers around the world.

The challenge of hospital infection control during a response to bioterrorist attacks.

  • R. GrowLewis Rubinson
  • Medicine, Political Science
    Biosecurity and bioterrorism : biodefense strategy, practice, and science
  • 2003
The focus is on the challenges that widespread implementation of rigorous infection control practices would pose to hospital operations, especially were hospitals required to deliver medical care for unusually high numbers of patients after a bioterrorist attack.

Being Prepared: Bioterrorism and Mass Prophylaxis: Part I

This two-part review of bioterrorism will focus on the clinical presentation and treatment of anthrax, plague, and tularemia, and the provision of mass prophylaxis.

Evaluation of perceived threat differences posed by filovirus variants.

It is concluded that, based on currently available data, filovirus biodefense research ought to focus on the classical taxonomic filov virus prototypes: Marburg virus Musoke in the case of marburgviruses and Ebola virus Mayinga in the cases of Zaire ebolaviruses.

Research on prevention and treatment of hemorrhagic fevers.

An overview of different approaches used in combating the viral hemorrhagic fevers is given and results of the latest studies are promising and encourage further work which may eventually lead to the solution of the urgent problem of hemorrhagicFevers.
...

References

SHOWING 1-10 OF 163 REFERENCES

Tularemia as a biological weapon: medical and public health management.

OBJECTIVE The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a

Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Specific consensus recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs.

Botulinum toxin as a biological weapon: medical and public health management.

People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months.

Perspectives in fatal epidemics.

Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection Control, home care, decontamination of the environment, and additional research needs.

The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

In May 1995, an international team characterized and contained an outbreak of Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo, and terminated by the initiation of barrier-nursing techniques, health education efforts, and rapid identification of cases.

Unexpected Ebola virus in a tertiary setting: Clinical and epidemiologic aspects

Identification of high‐risk patients and use of universal blood and body fluid precautions will considerably decrease the risk of nosocomial spread of viral hemorrhagic fevers.

Yellow fever: an update.

  • T. Monath
  • Medicine
    The Lancet. Infectious diseases
  • 2001

Clinical recognition and management of patients exposed to biological warfare agents.

An updated primer on 11 classic BW and potential terrorist agents is provided to increase the likelihood of their being considered in a differential diagnosis.

Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure.

Although close contact while caring for an infected person was probably the major route of transmission in this and previous EHF outbreaks, the virus may have been transmitted by touch, droplet, airborne particle, or fomite; thus, expansion of the use of barrier techniques to include casual contacts might prevent or mitigate future epidemics.
...